Global Blood Therapeutics Investor Relations Material
Latest events
Investor Conference 2022
Global Blood Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Global Blood Therapeutics Inc
Access all reports
Global Blood Therapeutics Inc. is a biopharmaceutical company focused on developing and delivering treatments for blood disorders. The company is primarily known for its work in addressing sickle cell disease, offering innovative therapies aimed at improving the quality of life for patients suffering from this and other blood-related conditions. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
GBT
Country
🇺🇸 United States